Pharmaplast S.a.e.
Pharmaplast S.a.e. (Egypt) has no DMF, CEP or site registration linked in our records. 15 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Pharmaplast S.a.e.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/pharmaplast-s-a-e
Overview
Pharmaplast S.a.e. is a medical device company based in Egypt.
FDA compliance signals
15 FDA enforcement records linked to this company.
- 4832025-02-06
Computer control of master formula records
- 4832025-02-06
Lack of written stability program
- 4832025-02-06
Procedures not in writing, fully followed
- 4832025-02-06
Prepared for each batch, include complete information
- 4832025-02-06
Scientifically sound laboratory controls
- 4832025-02-06
Approve or reject components, products
- 4832025-02-06
Complete test data included in records
- warning_letter2023-04-13
FDA Warning Letter (drug product)
- 4832022-11-10
Written procedures not established/followed
- 4832022-11-10
Documentation of Actual Yield and Theoretical Yield
- 4832022-11-10
Potable water not under positive pressure
- 4832022-11-10
Component identification test
- 4832022-11-10
GMP Training Frequency
- 4832022-11-10
Testing and release for distribution
- 4832022-11-10
Batch production and Batch Control Record Requirements
Is this Pharmaplast S.a.e.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.